本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Regenxbio Inc

7.98
+0.03500.44%
盤後7.990.0077+0.10%17:01 EDT
成交量:123.11萬
成交額:969.70萬
市值:5.27億
市盈率:-2.12
高:7.99
開:7.93
低:7.64
收:7.95
52周最高:16.19
52周最低:5.46
股本:6,601.32萬
流通股本:5,734.27萬
量比:1.04
換手率:2.15%
股息:- -
股息率:- -
每股收益(TTM):-3.7652
每股收益(LYR):-3.7593
淨資產收益率:-137.63%
總資產收益率:-21.20%
市淨率:7.34
市盈率(LYR):-2.12

資料載入中...

2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals